Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report - PubMed
Review
. 2007 Nov;30(11):1445-59.
doi: 10.1093/sleep/30.11.1445.
Teofilo Lee-Chiong, Cathy Alessi, Leah Friedman, R Nisha Aurora, Brian Boehlecke, Terry Brown, Andrew L Chesson Jr, Vishesh Kapur, Rama Maganti, Judith Owens, Jeffrey Pancer, Todd J Swick, Rochelle Zak; Standards of Practice Committee of the American Academy of Sleep Medicine
Affiliations
- PMID: 18041479
- PMCID: PMC2082098
- DOI: 10.1093/sleep/30.11.1445
Review
Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An American Academy of Sleep Medicine report
Timothy I Morgenthaler et al. Sleep. 2007 Nov.
Erratum in
- Sleep. 2008 Jul 1;31(7):table of contents
Abstract
The expanding science of circadian rhythm biology and a growing literature in human clinical research on circadian rhythm sleep disorders (CRSDs) prompted the American Academy of Sleep Medicine (AASM) to convene a task force of experts to write a review of this important topic. Due to the extensive nature of the disorders covered, the review was written in two sections. The first review paper, in addition to providing a general introduction to circadian biology, addresses "exogenous" circadian rhythm sleep disorders, including shift work disorder (SWD) and jet lag disorder (JLD). The second review paper addresses the "endogenous" circadian rhythm sleep disorders, including advanced sleep phase disorder (ASPD), delayed sleep phase disorder (DSPD), irregular sleep-wake rhythm (ISWR), and the non-24-hour sleep-wake syndrome (nonentrained type) or free-running disorder (FRD). These practice parameters were developed by the Standards of Practice Committee and reviewed and approved by the Board of Directors of the AASM to present recommendations for the assessment and treatment of CRSDs based on the two accompanying comprehensive reviews. The main diagnostic tools considered include sleep logs, actigraphy, the Morningness-Eveningness Questionnaire (MEQ), circadian phase markers, and polysomnography. Use of a sleep log or diary is indicated in the assessment of patients with a suspected circadian rhythm sleep disorder (Guideline). Actigraphy is indicated to assist in evaluation of patients suspected of circadian rhythm disorders (strength of recommendation varies from "Option" to "Guideline," depending on the suspected CRSD). Polysomnography is not routinely indicated for the diagnosis of CRSDs, but may be indicated to rule out another primary sleep disorder (Standard). There is insufficient evidence to justify the use of MEQ for the routine clinical evaluation of CRSDs (Option). Circadian phase markers are useful to determine circadian phase and confirm the diagnosis of FRD in sighted and unsighted patients but there is insufficient evidence to recommend their routine use in the diagnosis of SWD, JLD, ASPD, DSPD, or ISWR (Option). Additionally, actigraphy is useful as an outcome measure in evaluating the response to treatment for CRSDs (Guideline). A range of therapeutic interventions were considered including planned sleep schedules, timed light exposure, timed melatonin doses, hypnotics, stimulants, and alerting agents. Planned or prescribed sleep schedules are indicated in SWD (Standard) and in JLD, DSPD, ASPD, ISWR (excluding elderly-demented/nursing home residents), and FRD (Option). Specifically dosed and timed light exposure is indicated for each of the circadian disorders with variable success (Option). Timed melatonin administration is indicated for JLD (Standard); SWD, DSPD, and FRD in unsighted persons (Guideline); and for ASPD, FRD in sighted individuals, and for ISWR in children with moderate to severe psychomotor retardation (Option). Hypnotic medications may be indicated to promote or improve daytime sleep among night shift workers (Guideline) and to treat jet lag-induced insomnia (Option). Stimulants may be indicated to improve alertness in JLD and SWD (Option) but may have risks that must be weighed prior to use. Modafinil may be indicated to improve alertness during the night shift for patients with SWD (Guideline).
Similar articles
-
Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, Vitiello MV, Zhdanova IV; American Academy of Sleep Medicine. Sack RL, et al. Sleep. 2007 Nov;30(11):1484-501. doi: 10.1093/sleep/30.11.1484. Sleep. 2007. PMID: 18041481 Free PMC article. Review.
-
Sack RL, Auckley D, Auger RR, Carskadon MA, Wright KP Jr, Vitiello MV, Zhdanova IV; American Academy of Sleep Medicine. Sack RL, et al. Sleep. 2007 Nov;30(11):1460-83. doi: 10.1093/sleep/30.11.1460. Sleep. 2007. PMID: 18041480 Free PMC article. Review.
-
Smith MT, McCrae CS, Cheung J, Martin JL, Harrod CG, Heald JL, Carden KA. Smith MT, et al. J Clin Sleep Med. 2018 Jul 15;14(7):1231-1237. doi: 10.5664/jcsm.7230. J Clin Sleep Med. 2018. PMID: 29991437 Free PMC article.
-
[Circadian rhythm sleep disorder].
Mishima K. Mishima K. Nihon Rinsho. 2013 Dec;71(12):2103-8. Nihon Rinsho. 2013. PMID: 24437262 Review. Japanese.
-
Pandi-Perumal SR, Trakht I, Spence DW, Srinivasan V, Dagan Y, Cardinali DP. Pandi-Perumal SR, et al. Nat Clin Pract Neurol. 2008 Aug;4(8):436-47. doi: 10.1038/ncpneuro0847. Epub 2008 Jul 15. Nat Clin Pract Neurol. 2008. PMID: 18628753 Review.
Cited by
-
Caldarelli V, Borel JC, Khirani S, Ramirez A, Cutrera R, Pépin JL, Fauroux B. Caldarelli V, et al. Intensive Care Med. 2013 Apr;39(4):739-46. doi: 10.1007/s00134-012-2806-7. Epub 2013 Jan 24. Intensive Care Med. 2013. PMID: 23344829
-
Circadian rhythm abnormalities.
Zee PC, Attarian H, Videnovic A. Zee PC, et al. Continuum (Minneap Minn). 2013 Feb;19(1 Sleep Disorders):132-47. doi: 10.1212/01.CON.0000427209.21177.aa. Continuum (Minneap Minn). 2013. PMID: 23385698 Free PMC article. Review.
-
Harrison EM, Schmied EA, Hurtado SL, Easterling AP, Glickman GL. Harrison EM, et al. Int J Environ Res Public Health. 2022 Mar 6;19(5):3093. doi: 10.3390/ijerph19053093. Int J Environ Res Public Health. 2022. PMID: 35270786 Free PMC article.
-
Lehrer HM, Yao Z, Krafty RT, Evans MA, Buysse DJ, Kravitz HM, Matthews KA, Gold EB, Harlow SD, Samuelsson LB, Hall MH. Lehrer HM, et al. Sleep Adv. 2022 Feb 19;3(1):zpac001. doi: 10.1093/sleepadvances/zpac001. eCollection 2022. Sleep Adv. 2022. PMID: 35296109 Free PMC article.
-
Schneider JP, Matthews M, Jamison RN. Schneider JP, et al. CNS Drugs. 2010 Oct;24(10):805-10. doi: 10.2165/11584260-000000000-00000. CNS Drugs. 2010. PMID: 20839893 Review.
References
-
- Levels of Evidence. Oxford Centre for Evidence Based Medicine Web site. [Accessed June 23, 2007]. Available at: http://www.cebm.net/?o=1011.
-
- Eddy D. Philadelphia: American College of Physicians; 1992. A manual for assessing health practices and designing practice policies: the explicit approach.
-
- American Academy of Sleep Medicine. The international classification of sleep disorders: diagnostic & coding manual. 2nd ed. Westchester, IL: American Academy of Sleep Medicine; 2005.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources